[144] Nektar Therapeutics SEC Filing

Rhea-AI Filing Summary

Nektar Therapeutics (NKTR) Form 144 notice for proposed sale of securities. An insider intends to sell 485 shares of common stock via Fidelity Brokerage Services on NASDAQ, with an aggregate market value of $14,600.10 and an approximate sale date of 09/02/2025. The shares were acquired by restricted stock vesting on 11/15/2023 and were issued as compensation. The form also discloses a recent sale by the same person of 725 shares on 08/19/2025 for gross proceeds of $19,277.83. The filer certifies no undisclosed material adverse information and includes standard Rule 144 and 10b5-1 representations.

Positive

• None.

Negative

• Insider sale disclosed: Proposed sale of 485 common shares and a recent sale of 725 shares are reported, which may attract investor attention despite small size

Insights

Securities Analyst

TL;DR: Small insider sale under Rule 144; routine compliance filing, limited market impact.

The filing reports a planned sale of 485 shares valued at $14,600.10 and a prior sale of 725 shares producing $19,277.83. Both transactions appear to derive from vested restricted stock awarded as compensation, indicating these are non-open-market grants being liquidated under Rule 144 procedures. Given the small absolute dollar amounts relative to typical market capitalizations, this filing is likely administrative and not a material indicator of company fundamentals or a major shift in insider sentiment.

Corporate Governance Expert

TL;DR: Disclosure aligns with Rule 144 requirements; signature attestation and 10b5-1 language present.

The document provides the required insider attestation and identifies the broker and planned sale date. It confirms acquisition by restricted stock vesting and payment characterized as compensation, which supports a standard compliance environment for insider disposals. No indications of reliance on a 10b5-1 plan date are provided in the remarks section, so any plan reliance is not asserted here. From a governance perspective, the filing fulfills disclosure obligations but contains limited information for assessing motive or timing beyond compliance.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	485	14600.10	19018573	09/02/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/15/2023	Restricted Stock Vesting	Issuer			485	11/15/2023	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Jonathan Zalevsky 455 Mission Bay Boulevard South San Francisco CA 94158	Common	08/19/2025	725	19277.83

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for NKTR disclose about the proposed sale?

The Form 144 states a proposed sale of 485 common shares via Fidelity on NASDAQ with an aggregate market value of $14,600.10 and an approximate sale date of 09/02/2025.

How were the securities acquired according to the filing?

The securities were acquired through restricted stock vesting on 11/15/2023 and were recorded as compensation.

Did the filer report recent sales in the past three months?

Yes. The filing discloses a prior sale of 725 shares on 08/19/2025 for gross proceeds of $19,277.83.

Is there any statement about material nonpublic information in the filing?

The person signing the notice represents by signature that they do not know any material adverse information about the issuer that has not been publicly disclosed.

Which broker is handling the proposed sale?

The listed broker is Fidelity Brokerage Services LLC located at the address shown in the filing.